Common Fatty Markers in Diseases with Dysregulated Lipogenesis

Balgoma Hernando, David; Perttersson, Curt; Hedeland, Mikael

doi:10.1016/J.TEM.2019.02.008

Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/74591

Título

Common Fatty Markers in Diseases with Dysregulated Lipogenesis

Autor

Balgoma Hernando, David

Perttersson, Curt

Hedeland, Mikael

Año del Documento

2019

Editorial

CellPress

Descripción

Producción Científica

Documento Fuente

Trends Endocrinol Metab . 2019 May;30(5):283-285

Abstract

Recent studies have reported the upregulation of a subgroup of triacylglycerides as markers of different diseases with dysregulated lipogenesis, which means that these markers are not selective. This observation has a deep impact on their use as diagnostic tools in clinical practice (e.g., markers of risk of type 2 diabetes).

ISSN

1043-2760

Revisión por pares

DOI

10.1016/J.TEM.2019.02.008

Version del Editor

https://www.cell.com/trends/endocrinology-metabolism/fulltext/S1043-2760(19)30041-4